What are the characteristics of EMEIS stock?

EMEIS is a company operating in the Santé · Etablissements de santé / EHPAD sector. The stock is listed on Euronext Paris under ISIN FR001400NLM4.

What is the recent price evolution of EMEIS stock?

Since last close: -1.24 %. Over one week: -0.26 %. Over one year: 39.54 %.

EMEIS Appoints Jean-Marc Boursier as Deputy CEO Effective July 1

Jean-Marc Boursier, currently the Deputy CEO, has been appointed as the Deputy CEO by the EMEIS board of directors on April 24, 2026. He will assume his new role from July 1, 2026, while continuing as the Group CFO.

Published on Apr 27, 2026 at 10:51

EMEIS

15.14 € -1.24 %

Professional Background and Career Progression

Jean-Marc Boursier, an engineer graduated from Télécom Sud Paris and holder of a Master's degree in Finance from HEC, joined EMEIS on September 1, 2024, as Group CFO. From April 1, 2025, he was promoted to Deputy CEO, with expanded responsibilities including oversight of Central Europe and Latin America. Prior to joining EMEIS, he served as CFO and COO of SUEZ Group.

Appointment Aligned with Renewed CEO Mandate

Free · Every morning

Technical market signals, before the opening bell.

Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.

✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis

Indicative data. No investment advice. Unsubscribe at any time.

This appointment follows the renewal of Laurent Guillot's mandate as CEO of EMEIS, decided by the board on April 7, 2026. Laurent Guillot highlighted that 'Jean-Marc Boursier's appointment comes at a pivotal time in EMEIS's history, after four years dedicated to the Group's foundational restructuring and financial overhaul,' adding that this move 'will accelerate our efforts to achieve our ambitions.'

🏢 Other stocks — Santé

🗞️ MedInCell Stock Drops 2% to €28.14 Despite Raised Target of €52 by Oddo 🗞️ Sartorius Stedim Biotech Shares Slide to €159.10, Remain Under Technical Pressure 🗞️ Nanobiotix Shares Drop to €44.46 After a 1,181% Annual Surge and a Record High of €45.86 🗞️ DBV Technologies Shares at €3.44: Up 77% Over the Year, Heading to the June 3rd General Meeting

Context

Period

Period: 1T2026

Key reported figures

Revenue: 1509M€

Risks mentioned

Les mesures de qualité engagées en 2024 et 2025 sont essentielles.
La demande de lits devrait dépasser l'offre de 550 000 d'ici 2030.

Opportunities identified

Croissance organique de +6,3 % au 1T2026, soutenue par des taux d'occupation améliorés.
Réduction de la sensibilité aux pressions inflationnistes grâce à un hedging sur 90 % des dépenses énergétiques.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Professional Background and Career Progression

Appointment Aligned with Renewed CEO Mandate

Context

Also read